Partnering with Amgen vet Sean Harper, veteran VC Beth Seidenberg unveils a $320M fund and a unique focus on…wait for it…LA
Beth Seidenberg is ending a brief quiet spell this morning, fulfilling expectations that she was piecing together her own biotech venture fund — and adding a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.